The Nomination Committee of Cavotec SA (“Cavotec”) consists of members appointed by Cavotec’s Board of Directors, in accordance with Cavotec's Internal Regulations. The composition of the members of the Nomination Committee presented below is in line with the recommendations of the
Further improved profitability on the back of stable revenues July–September 2019 Order intake increased 36.1% to EUR 50.6 million (37.2) Revenue decreased -1.5% to EUR 48.4 million (49.2) EBIT excluding non-recurring items amounted to EUR 3.7 million (2.1), corresponding to a margin of 7.6%
Cavotec SA will publish its Q3 report 2019, 8 November 2019 at 07:00 CET. A conference call, including a short presentation of the report for shareholders, analysts and media will be held 8 November at 10:00 CET, followed by a Q&A session. The presentation will be held by Cavotec’s CEO Mikael
Significantly improved profits on the back of stable revenue April–June 2019 Order intake decreased 26.7% to EUR 45.5 million (62.1) Revenue increased 11% to EUR 51.4 million (46.3) Adjusted EBIT amounted to EUR 3.7 million (-0.7), corresponding to a margin of 7.1% (-1.6%) Non-recurring items
Cavotec SA will publish its Q2 report 2019, 31 July 2019 at 07:00 CEST. A conference call, including a short presentation of the report for shareholders, analysts and media will be held 31 July at 10:00 CEST, followed by a Q&A session. The presentation will be held by Cavotec’s CEO Mikael Norin
As previously reported in relation to the case of Cavotec vs. Michael Colaco et al, both parties filed petitions for the court to settle the amounts owed by each party in the case. The Superior Court of California has now entered a judgment and instructed Cavotec to make a payout of USD 9.1
Cavotec SA ("the Company") today held its Annual General Meeting ("AGM") in Lugano, Switzerland, chaired by Patrik Tigerschiöld. Annual Report, Financial Statements and Consolidated Financial Statements for the year 2018, Report of the Statutory Auditors The AGM adopted the Board of Directors'
Today, 7 May, at 13.30 Cavotec SA (“Cavotec or the Company”) will hold its Investor Information Meeting 2019 in Stockholm. CEO Mikael Norin together with members of the executive management team will give an update on the transformation of Cavotec, the next chapter of the Company’s strategy and the
Organic annual revenue growth of at least 5% from 2020, in addition to possible acquisitions An annual adjusted EBIT margin of more than 7% within two years and more than 10% within four years Dividends of approximately 30-50% of net profits over a business cycle Over the past five quarters,
Transformation measures reflected in higher profitability despite lower revenue – continued strong order book January–March 2019 Order intake decreased 9.3% to EUR 61.6 million (67.9) Order book increased 12.4% to EUR 113.2 million (100.8) Revenues decreased 8.0% to EUR 48.5 million (52.7) EBIT
